Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,955 | 5,510 | 0 | 0 | 0 |
| Marketable Securities | 21,930 | 25,735 | 0 | 0 | 0 |
| TOTAL | $30,038 | $32,461 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 734 | 743 | N/A | N/A | N/A |
| Other Non-Current Assets | 3,522 | 2,147 | 0 | 0 | 0 |
| TOTAL | $4,256 | $2,890 | $N/A | $N/A | $N/A |
| Total Assets | $34,294 | $35,351 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 947 | 1,666 | 0 | 0 | 0 |
| Accrued Expenses | 7,856 | 5,437 | 0 | 0 | 0 |
| Other current liabilities | 31 | 34 | 0 | 0 | 0 |
| TOTAL | $16,075 | $14,382 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,583 | 10,241 | 0 | 0 | 0 |
| Deferred Revenues | 41 | 45 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 142,496 | 135,077 | 0 | 0 | 0 |
| TOTAL | $151,140 | $145,386 | $N/A | $N/A | $N/A |
| Total Liabilities | $167,215 | $159,768 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 53 | N/A | N/A | N/A | N/A |
| Common Shares | 2 | 2 | 0 | 0 | 0 |
| Retained earnings | -137,073 | -128,000 | 0 | 0 | 0 |
| Other shareholders' equity | -1 | 0 | 0 | 0 | 0 |
| TOTAL | $-132,921 | $-124,417 | $0 | $0 | $0 |
| Total Liabilities And Equity | $34,294 | $35,351 | $0 | $0 | $0 |